EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques

Ziyu Wen iD, Pingchao Li, Yue Yuan, Congcong Wang, Minchao Li, Haohang Wang, Minjuan Shi, Yizi He, Mingting Cui, Ling Chen, Caijun Sun iD

eLife · 2025

DOI: 10.7554/elife.95964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Ziyu Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Virus Latency, Simian Immunodeficiency Virus, Simian Acquired Immunodeficiency Syndrome, Herpesvirus 1, Human. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Science Foundation of China, Science and Technology Planning Project of Guangdong Province, shenzhen key laboratory of pathogenic microbes and biosafety.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The persistence of latent viral reservoirs remains the major obstacle to eradicating human immunodeficiency virus (HIV). We herein found that ICP34.5 can act as an antagonistic factor for the reactivation of HIV latency by herpes simplex virus type I (HSV-1), and thus recombinant HSV-1 with ICP34.5 deletion could more effectively reactivate HIV latency than its wild-type counterpart. Mechanistically, HSV-ΔICP34.5 promoted the phosphorylation of HSF1 by decreasing the recruitment of protein phosphatase 1 (PP1α), thus effectively binding to the HIV LTR to reactivate the latent reservoirs. In addition, HSV-ΔICP34.5 enhanced the phosphorylation of IKKα/β through the degradation of IκBα, leading to p65 accumulation in the nucleus to elicit NF-κB pathway-dependent reactivation of HIV latency. Then, we constructed the recombinant HSV-ΔICP34.5 expressing simian immunodeficiency virus (SIV) env, gag, or the fusion antigen sPD1-SIVgag as a therapeutic vaccine, aiming to achieve a functional cure by simultaneously reactivating viral latency and eliciting antigen-specific immune responses. Results showed that these constructs effectively elicited SIV-specific immune responses, reactivated SIV latency, and delayed viral rebound after the interruption of antiretroviral therapy (ART) in chronically SIV-infected rhesus macaques. Collectively, these findings provide insights into the rational design of HSV-vectored therapeutic strategies for pursuing an HIV functional cure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus LatencySimian Immunodeficiency VirusSimian Acquired Immunodeficiency SyndromeHerpesvirus 1, HumanSAIDS VaccinesAnimalsGenetic VectorsMacaca mulattaHumansVirus Activation

Stichwörter der Autor:innen

HIVHSVSIVfunctional cureinfectious diseasemicrobiologyrhesus macaquetherapeutic vaccineviruses

Substanzen

SAIDS Vaccines

Autor:innen und Institutionen

  • School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
  • State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Guangzhou, China.
  • Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
  • Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
  • State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Ziyu Wen, Caijun Sun

Förderung

  • National Nature Science Foundation of China
  • Science and Technology Planning Project of Guangdong Province
  • shenzhen key laboratory of pathogenic microbes and biosafety
  • the sanming project of medicine in shenzhen nanshan
  • National Natural Science Foundation of China

Zitieren

APA

Wen, Z., Li, P., Yuan, Y., Wang, C., Li, M., Wang, H., Shi, M., He, Y., Cui, M., Chen, L., & Sun, C. (2025). Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques. eLife. https://doi.org/10.7554/elife.95964

Vancouver

Wen Z, Li P, Yuan Y, Wang C, Li M, Wang H, et al. Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques. eLife. 2025. doi:10.7554/elife.95964

BibTeX
@article{Wen2025,
  author = {Wen, Ziyu and Li, Pingchao and Yuan, Yue and Wang, Congcong and Li, Minchao and Wang, Haohang and Shi, Minjuan and He, Yizi and Cui, Mingting and Chen, Ling and Sun, Caijun},
  title = {Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.95964}
}
Kostenlos starten →